Our teams are working hard to get you the latest advice on Covid-19

Our helpline is providing vital support and advice to more people than ever. Help us be there for

every call by donating today – it really does make a difference. Thank you.

Save for later

Helping young people with Type 1 diabetes produce their own insulin - USTEKID trial

December 2018
December 2022
UK-wide
Cardiff and Swansea Universities
Helping young people with Type 1 diabetes produce their own insulin - USTEKID trial

Type 1 diabetes is caused by the body's own immune system damaging the cells in the pancreas that make insulin. Researchers at Cardiff and Swansea Universities would like to develop a treatment that can slow this process down, by targeting the immune cells causing the damage.

They'd like people aged 12-18 years who have been diagnosed with Type 1 diabetes within the last 100 days to take part in their study, testing a new medicine called Ustekinumab. When first diagnosed with Type 1 diabetes, most people still have 10-20% of their insulin-producing cells still working. The researchers believe this new medicine could help the pancreas make insulin for longer. 

Taking part involves eight visits over 12 months to receive the drug (or a placebo (dummy) drug), and blood and urine tests. As a thank you, study volunteers will receive a £10 gift voucher for each visit and £30 gift voucher for the final, eighth visit. 

For more information contact T1D UK Immunotherapy ConsortiumT1DUK@cardiff.ac.uk, or USTEKID@swansea.ac.uk.

Brand Icons/Telephone check - FontAwesome icons/tick icons/uk